Hence, this study cannot be seen as a complete investigation of all off-label use of GLP-1 RAs
Khan MS, Fonarow GC, McGuire DK et al (2020) Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization
In a longer 104-week extension, weight loss reached up to 85 pounds (30.3%) in some participants with higher baseline BMI
For context on how this titration compares to other GLP-1 peptides, the compound tirzepatide dosing chart shows a similar step-wise approach, and the compounded semaglutide with B12 dosage chart illustrates the same concept for semaglutide
Because its a different delivery system, patients may experience less nausea and fewer adverse effects
Diabetes Care 46 , 19861992 (2023)